Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Weighting strategies for dividend ETFs retirees tailor allocations to income needs and risk tolerance. This overview covers common approaches and checks.
14,327 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Investors flocked to Ferroglobe after a midweek earnings update, turning a measured bounce into a genuine momentum pl...
A new financing path for accessory dwelling units could unlock bigger yields for landlords. This article breaks down ...
Can AI agents boost ethereum security? This piece explores a new testing ground where intelligent agents probe and pa...
Looking for no-brainer stocks right now? These three AI powerhouses—NVIDIA, MICROSOFT, and Alphabet—combined with pra...
Amazon tops Walmart in 2025 U.S. revenue, marking a historic shift toward tech-powered retail. The milestone could re...
The Supreme Court’s bombshell tariff decision blocks emergency levies but leaves unresolved how firms recover roughly...
Amazon is quietly expanding its in-house silicon beyond data center basics, pushing Graviton and Trainium into broade...
What could Nu Holdings look like a decade from now? This article breaks down growth catalysts, potential paths, and p...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
Tilray’s stock has been a rollercoaster, but deciding whether to time dump your shares depends on your portfolio, ris...
OpenAI has redefined its mission and governance, moving into a for-profit structure and removing safety language from...